Helper-free rescue of recombinant negative strand RNA virus
AssigneeMount Sinai School of Medicine of New York University
InventorsPeter Palese, Adolfo Garcia-Sastre, George G Brownlee, Ervin Fodor
Life of this patent
Estimating the term…
Loading patent…
AssigneeMount Sinai School of Medicine of New York University
InventorsPeter Palese, Adolfo Garcia-Sastre, George G Brownlee, Ervin Fodor
Estimating the term…
The present invention relates methods of generating infectious negative-strand virus in host cells by an entirely vector-based system without the aid of a helper virus. In particular, the present invention relates methods of generating infectious recombinant negative-strand RNA viruses intracellularly in the absence of helper virus from expression vectors comprising cDNAs encoding the viral proteins necessary to form ribonucleoprotein complexes (RNPs) and expression vectors comprising cDNA for genomic viral RNA(s) (vRNAs) or the corresponding cRNA(s). The present invention also relates to methods of generating infectious recombinant negative-strand RNA viruses which have mutations in viral genes and/or which express, package and/or present peptides or polypeptides encoded by heterologous nucleic acid sequences. The present invention further relates the use of the recombinant negative-strand RNA viruses or chimeric negative-strand RNA viruses of the invention in vaccine formulations and pharmaceutical compositions.
A method for producing influenza virus particles for preparation of a vaccine, comprising:
A method for producing influenza virus particles comprising producing in a cell all of the genomic RNA of an influenza virus by expressing from DNA introduced into the cell at least one or more of genomic RNA or cRNA of the influenza virus and producing in the cell RNA dependent RNA polymerase and nucleoprotein and assembling in the cell the influenza virus, said cell being free of helper virus, wherein said cell is selected from Vero cells and other cells which are deficient in interferon activity and capable of supporting growth of said virus.
A method for producing influenza virus particles for preparation of a vaccine, comprising:
Dependencies are inferred from the claim text.